Corcept Therapeutics
CORT
#2445
Rank
ยฃ4.79 B
Marketcap
ยฃ45.72
Share price
2.90%
Change (1 day)
126.24%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of November 2024 (TTM): 9.48

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.33. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.25-55.19%๐Ÿ‡บ๐Ÿ‡ธ USA
2.51-73.55%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19-55.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
17.4 83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
2.60-72.55%๐Ÿ‡บ๐Ÿ‡ธ USA
4.06-57.20%๐Ÿ‡บ๐Ÿ‡ธ USA
1.76-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
7.70-18.76%๐Ÿ‡บ๐Ÿ‡ธ USA
4.45-53.08%๐Ÿ‡บ๐Ÿ‡ธ USA